Compare USFD & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | USFD | ICLR |
|---|---|---|
| Founded | 2007 | 1990 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Food Distributors | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.8B | 7.1B |
| IPO Year | 2016 | 2001 |
| Metric | USFD | ICLR |
|---|---|---|
| Price | $92.15 | $96.67 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 13 |
| Target Price | $103.64 | ★ $182.08 |
| AVG Volume (30 Days) | ★ 2.2M | 1.5M |
| Earning Date | 05-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 45.54 | N/A |
| EPS | ★ 2.94 | N/A |
| Revenue | ★ $39,424,000,000.00 | N/A |
| Revenue This Year | $7.64 | N/A |
| Revenue Next Year | $3.99 | N/A |
| P/E Ratio | $32.20 | ★ $12.91 |
| Revenue Growth | ★ 4.08 | N/A |
| 52 Week Low | $57.36 | $66.57 |
| 52 Week High | $102.13 | $211.00 |
| Indicator | USFD | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 49.61 | 32.14 |
| Support Level | $75.17 | $66.57 |
| Resistance Level | $102.13 | $113.88 |
| Average True Range (ATR) | 2.33 | 4.86 |
| MACD | -0.68 | 1.71 |
| Stochastic Oscillator | 46.46 | 5.54 |
US Foods Holding Corp is the U.S. food service distributor that distributes food and nonfood products to the healthcare and hospitality industries, restaurants, and education, government facilities, and grocers. It has nearly 250,000 restaurants and foodservice operators with more than 70 locations that provide customers with food offering and a comprehensive suite of e-commerce, technology, and business solutions. The company operates in one business segment in which it markets, sells and distributes fresh, frozen and dry food and non-food products to foodservice customers throughout the U.S.
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.